ArticleJournal of translational medicine2010

Evaluation of six CTLA-4 polymorphisms in high-risk melanoma patients receiving adjuvant interferon therapy in the He13A/98 multicenter trial.

Helen Gogas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.